Table 2.
Treatment delivery
| Characteristic | Arm without CTV n (%) | Arm with CTV n (%) |
|---|---|---|
| No. of eligible patients |
54(100) |
35(100) |
| Treatment schedule |
|
|
| Induction chemo + RT |
6(11.1) |
8(22.9) |
| Concurrent chemo alone |
2(3.7) |
2(5.7) |
| Induction + concurrent t adjuvant chemo |
11(20.4) |
13(37.1) |
| Induction + concurrent chemo |
26(48.1) |
10(28.6) |
| Concurrent + adjuvant chemo |
8(14.8) |
2(5.7) |
| Induction + RT adjuvant chemo |
1(1.9) |
0(0) |
| Induction chemo (cycles) |
|
|
| 0 |
10(18.5) |
4(11.4) |
| 1 |
15(27.8) |
9(25.7) |
| 2 |
13(24.1) |
7(20.0) |
| ≥3 |
16(29.6) |
15(42.9) |
| Concurrent chemo (cycles) |
|
|
| 0 |
7(13.0) |
8(22.8) |
| 1 |
9(16.7) |
5(14.3) |
| 2 |
34(63.0) |
14(40.0) |
| 3 |
4(7.4) |
8(22.8) |
| Adjuvant chemo (cycles) |
|
|
| 0 |
34(63.0) |
20(57.1) |
| 1 |
8(14.8) |
5(14.3) |
| 2 |
11(20.4) |
9(25.7) |
| 3 |
1(1.9) |
1(2.9) |
| PCI |
|
|
| Without PCI |
25(46.3) |
18(51.4) |
| With PCI | 29(53.7) | 17(48.6) |